• Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Before Header

  • Axis Clinicals USA

Axis Clinicals

Contract Research Organization

  • Home
  • About Us
    • Our DNA
    • Our Core Values
    • Your Preferred Partner of Choice โ€“ WHY?
    • Our Focus
    • Our Leadership
    • Accreditations
    • Global Locations
  • Services
    • BA | BE Studies
    • PK | PD and Patient Studies
    • Bio-Analytical Services
    • Phase I
    • Phase II-IV
    • Project Management
    • PK | Biostatistics & Programming
    • Medical Writing
    • Regulatory Services
    • Quality Assurance and Compliance
    • Clinical Data Management
    • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us
  • Investors
    • Annual Report
    • Codes & Policies
      • 1. Vigil Mechanism Policy
      • 2. Corporate Social Responsibility Policy
      • 3. Criteria for Directors
      • 4. Nomination & Remuneration Policy
    • Corporate Social Responsibility
      • 1. Corporate Social Responsibility Policy
      • 2. Composition of CSR Committee
    • Annual Return
      • 1. FY 2020-21
      • 2. FY 2021-22
      • 3. FY 2022-23
  • Home
  • About Us
    • Our DNA
    • Our Core Values
    • Your Preferred Partner of Choice โ€“ WHY?
    • Our Focus
    • Our Leadership
    • Accreditations
    • Global Locations
  • Services
    • BA | BE Studies
    • PK | PD and Patient Studies
    • Bio-Analytical Services
    • Phase I
    • Phase II-IV
    • Project Management
    • PK | Biostatistics & Programming
    • Medical Writing
    • Regulatory Services
    • Quality Assurance and Compliance
    • Clinical Data Management
    • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us
  • Investors
    • Annual Report
    • Codes & Policies
      • 1. Vigil Mechanism Policy
      • 2. Corporate Social Responsibility Policy
      • 3. Criteria for Directors
      • 4. Nomination & Remuneration Policy
    • Corporate Social Responsibility
      • 1. Corporate Social Responsibility Policy
      • 2. Composition of CSR Committee
    • Annual Return
      • 1. FY 2020-21
      • 2. FY 2021-22
      • 3. FY 2022-23

Our DNA

You are here: Home / Our DNA

AXIS is an efficient, metric based clinical research provider with a global footprint of operations.

Our mandate recognizes the need within the medical research community for quality clinical services backed by experience, ICH/GCP training, protocol adherence, and leadership at significant cost advantages. Representing a vertically integrated CRO, we provide a collaborative and personalized approach to meet sponsor study requirements.

Offering trial management and monitoring, quality assurance, regulatory submissions, data management and biostatistics, makes us the assembly of a functional team ideally suited for clinical study. Our clients have ranged from big pharma majors to the emerging biotechnology sector. Our customized billing models help us add new clients along with the retention of our recurring clientele.

With over 3300+ studies for various regulated markets, a huge data bank of validated bio-analytical methods for over 550+ molecules and the facilities being inspected and approved by various global regulatory authorities, AXIS Clinicals ranks among the Top Clinical Research Organizations in India. As a Clinical Research Organization, our core competencies are in the realm of planning, designing and managing Clinical Trials – with clients that include national and international Pharmaceutical majors (innovators as well as generic pharmaceutical enterprises), Biotechnology and Medical Device organizations. Our clinical research programs employ the latest study designs in clinical pharmacology, Bio-Analytical method development and Pharmacokinetic analysis, conducted by a team of experienced and well-trained clinical coordinators and research associates.

AXIS Clinicals – A Promise to Precision in Clinical Research

Primary Sidebar

Menu

  • Home
  • About Us
    • Our DNA
    • Our Core Values
    • Your Preferred Partner of Choice โ€“ WHY?
    • Our Focus
    • Our Leadership
    • Accreditations
    • Global Locations
  • Services
    • BA | BE Studies
    • PK | PD and Patient Studies
    • Bio-Analytical Services
    • Phase I
    • Phase II-IV
    • Project Management
    • PK | Biostatistics & Programming
    • Medical Writing
    • Regulatory Services
    • Quality Assurance and Compliance
    • Clinical Data Management
    • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us
  • Investors
    • Annual Report
    • Codes & Policies
      • 1. Vigil Mechanism Policy
      • 2. Corporate Social Responsibility Policy
      • 3. Criteria for Directors
      • 4. Nomination & Remuneration Policy
    • Corporate Social Responsibility
      • 1. Corporate Social Responsibility Policy
      • 2. Composition of CSR Committee
    • Annual Return
      • 1. FY 2020-21
      • 2. FY 2021-22
      • 3. FY 2022-23

Footer

  • About Us
  • Our DNA
  • Our Core Values
  • Your Preferred Partner of Choice
  • Our Focus
  • Our Leadership
  • Accreditations
  • Global Locations
  • Services
  • BA | BE Studies
  • PK | PD and Patient Studies
  • Bio-Analytical Services
  • Phase II-IV
  • Project Management
  • PK | Biostatistics & Programming
  • Medical Writing
  • Regulatory Services
  • Quality Assurance and Compliance
  • Clinical Data Management
  • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us

Copyright © 2025 ยท Axis Clinicals